A series of thought-provoking blogs covering topics such as, “How can heat be mitigated in the BFS packaging process?” and “What are the barrier properties of resin?”.
ApiJect Expert Industry Insights
-
June 29, 2022
How Blow-Fill-Seal Delivers Operational Efficiencies and Aseptic Fill-Finish
with Joe Wojcik, Senior Director, Pharmaceutical Development ServicesPharma expert, Joe Wojcik, discusses the technical factors and requirements that make BFS an “advanced aseptic process” for fill-finish, and why BFS has relatively low capital requirements
READ HERE -
December 8, 2021
What Have Been the Biggest Surprises with COVID-19?
with Ed Kelley, PhD, Chief Global Health OfficerThe pandemic’s effects have been far more wide-reaching than many health officials expected, but COVID has also accelerated some positive trends.
READ HERE -
November 9, 2021
Advances in Sterile Liquids Packaging and Form Factors
with Jon Burgess, General Manager, Technology Development CenterDiscussion on packaging factors that have led to wider acceptance of Blow-Fill-Seal technology in the pharmaceutical industry.
READ HERE -
November 2, 2021
Strengths of Diversity in Pharma
with Amy Stewart, Chief People OfficerCompanies are realizing that a strong commitment to DEI and ESG attracts employees. Word of mouth is very powerful. Companies want to do business with partners that are inclusive with positive values and environmental initiatives.
READ HERE -
July 30, 2021
The Surprising Strengths of Blow-Fill-Seal
with Philip Leslie, Senior Advisor, Manufacturing
Why does the FDA calls BFS an “advanced aseptic process”? How does BFS combine high-speed, economically efficient production with notable manufacturing flexibility? Respected industry veteran Philip Leslie explains “the basics of BFS.”READ HERE -
March 3, 2021
The Heat Factor: Part 1 & 2:Why it Matters in Blow-Fill-Seal
with Jeff Price, Consulting Principal BFS EngineerAt ApiJect, our engineers have taken BFS filling enhancements even further by developing proprietary temperature control management methods that can potentially enable many temperature sensitive biologics and vaccines that are not possible on standard BFS lines.
READ HERE
